Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hensel, M."" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukaemia in clinical practice.
Autorzy:
Reiser M; Praxis internistischer und onkologischer Hämatologie (PIOH), Cologne, Germany.
Dörfel S; Onkozentrum Dresden, Dresden, Germany.
Hensel M; Mannheimer Onkologie Praxis, Mannheim, Germany.
Hoesl M; Internistische Gemeinschaftspraxis - Praxisklinik, Nürnberg, Germany.
Jordan WO; Facharztpraxis innere Medizin, Hämatologie, Onkologie, Berlin, Germany.
Koenigsmann M; Onkologisches Ambulanzzentrum (OAZ) Hannover, Hannover, Germany.
Meyer D; Onkologische Praxis, Göttingen, Germany.
Reichert D; Onkologie, Westerstede, Germany.
Schwarzer A; Gemeinschaftspraxis für Hämatologie und Onkologie, Leipzig, Germany.
Marquardt M; Roche Pharma AG, Grenzach-Wyhlen, Germany.
Kellershohn K; Roche Pharma AG, Grenzach-Wyhlen, Germany.
Jentsch-Ullrich K; Schwerpunktpraxis für Hämatologie und Onkologie, Magdeburg, Germany.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2018 May; Vol. 100 (5), pp. 455-464. Date of Electronic Publication: 2018 Mar 22.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Drug Resistance, Neoplasm ; Female ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Male ; Middle Aged ; Neoplasm Staging ; Prospective Studies ; Recurrence ; Rituximab/administration & dosage ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł:
FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia.
Autorzy:
Kutsch N; a Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University Hospital of Cologne , Cologne , Germany.
Busch R; b Institute of Medical Statistics and Epidemiology , Technical University , Munich , Germany.
Bahlo J; a Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University Hospital of Cologne , Cologne , Germany.
Mayer J; c Department of Internal Medicine, Hematology and Oncology , University Hospital Brno , Brno , Czech Republic.
Hensel M; d Internal Medicine V , University of Heidelberg , Heidelberg , Germany.
Hopfinger G; e Department of Internal Medicine I, Vienna General Hospital, Medical University of Vienna , Vienna , Austria.
Hess G; f Department of Hematology and Oncology , Johannes Gutenberg-Universitat , Mainz , Germany.
von Grünhagen U; g Praxis fur Hamatologie und Onkologie , Cottbus , Germany.
Wendtner CM; a Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University Hospital of Cologne , Cologne , Germany.; h Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine , Klinikum Schwabing , Munich , Germany.
Maria Fink A; a Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University Hospital of Cologne , Cologne , Germany.
Fischer K; a Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University Hospital of Cologne , Cologne , Germany.
Hallek M; a Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University Hospital of Cologne , Cologne , Germany.
Eichhorst B; a Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University Hospital of Cologne , Cologne , Germany.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2017 Feb; Vol. 58 (2), pp. 399-407. Date of Electronic Publication: 2016 Jun 29.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study
MeSH Terms:
Quality of Life*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Case-Control Studies ; Cyclophosphamide/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Male ; Medication Adherence ; Middle Aged ; Rituximab/administration & dosage ; Sex Factors ; Surveys and Questionnaires ; Treatment Outcome ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives
Czasopismo naukowe
Tytuł:
Secondary follicular lymphoma of the bone, transformed into large cell lymphoma, in a patient with chronic lymphocytic leukaemia: an uncommon manifestation of Richter's syndrome.
Autorzy:
Hensel M; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. manfred_hensel@med.uni-heidelberg.de
Buss EC
Tiemann M
Parwaresch R
Libicher M
Fruehauf S
Ho AD
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2004 Mar; Vol. 72 (3), pp. 217-21.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bone Neoplasms/*pathology
Leukemia, Lymphocytic, Chronic, B-Cell/*complications
Lymphoma, Follicular/*pathology
Lymphoma, Large B-Cell, Diffuse/*pathology
Neoplasms, Second Primary/*pathology
Aged ; Bone Neoplasms/etiology ; Cell Transformation, Neoplastic ; Female ; Humans ; Immunohistochemistry ; Immunophenotyping ; Lymphoma, Follicular/etiology ; Lymphoma, Large B-Cell, Diffuse/etiology ; Radiography ; Syndrome ; Tibia/diagnostic imaging ; Tibia/pathology
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies